Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bevacizumab and Metabolic Control for Diabetic Macular Edema
NCT02308644Phase 3Completed
- Sponsor
- Universidade de São Paulo
- Start
- Feb 2009
- Primary completion
- Dec 2011
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 3 trial of bevacizumab in diabetic macular edema (DME), sponsored by Universidade de São Paulo. Started Feb 2009; status: completed.
02
Drugs
bevacizumab
03
Conditions
diabetic macular edema (DME)
Beyond the preview
Go deeper on NCT02308644.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02308644.